{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:41:46Z","timestamp":1791200506364,"version":"4.2.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.biopsych.2012.01.003","type":"journal-article","created":{"date-parts":[[2012,2,10]],"date-time":"2012-02-10T17:54:15Z","timestamp":1328896455000},"page":"290-295","source":"Crossref","is-referenced-by-count":141,"title":["The Relationship Between Toxoplasma Gondii Infection and Mood Disorders in the Third National Health and Nutrition Survey"],"prefix":"10.1016","volume":"72","author":[{"given":"Brad D.","family":"Pearce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna","family":"Kruszon-Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2012.01.003_bib1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/aje\/154.4.357","article-title":"Toxoplasma gondii infection in the United States: Seroprevalence and risk factors","volume":"154","author":"Jones","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.biopsych.2012.01.003_bib2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/schbul\/sbl050","article-title":"Antibodies to Toxoplasma gondii in patients with schizophrenia: A meta-analysis","volume":"33","author":"Torrey","year":"2007","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2012.01.003_bib3","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1098\/rspb.2000.1182","article-title":"Fatal attraction in rats infected with Toxoplasma gondii","volume":"267","author":"Berdoy","year":"2000","journal-title":"Proc Biol Sci"},{"key":"10.1016\/j.biopsych.2012.01.003_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.14411\/fp.2010.012","article-title":"Toxoplasma gondii-altered host behaviour: Clues as to mechanism of action","volume":"57","author":"Webster","year":"2010","journal-title":"Folia Parasitol"},{"key":"10.1016\/j.biopsych.2012.01.003_bib5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/schbul\/sbm008","article-title":"Effects of Toxoplasma gondii infection on the brain","volume":"33","author":"Carruthers","year":"2007","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2012.01.003_bib6","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1056\/NEJM196512092732404","article-title":"Isolation of the encysted form of Toxoplasma gondii from human skeletal muscle and brain","volume":"273","author":"Remington","year":"1965","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biopsych.2012.01.003_bib7","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1073\/pnas.0608310104","article-title":"Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors","volume":"104","author":"Vyas","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2012.01.003_bib8","doi-asserted-by":"crossref","first-page":"e23866","DOI":"10.1371\/journal.pone.0023866","article-title":"The neurotropic parasite toxoplasma gondii increases dopamine metabolism","volume":"6","author":"Prandovszky","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.biopsych.2012.01.003_bib9","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/schbul\/sbm010","article-title":"A controlled prospective study of toxoplasma gondii infection in individuals with schizophrenia: Beyond seroprevalence","volume":"33","author":"Hinze-Selch","year":"2007","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2012.01.003_bib10","doi-asserted-by":"crossref","first-page":"e4801","DOI":"10.1371\/journal.pone.0004801","article-title":"A unique dual activity amino acid hydroxylase in Toxoplasma gondii","volume":"4","author":"Gaskell","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2012.01.003_bib11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/schbul\/sbm021","article-title":"Anti-Toxoplasma gondii antibodies in patients with schizophrenia\u2014preliminary findings in a Turkish sample","volume":"33","author":"Cetinkaya","year":"2007","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2012.01.003_bib12","doi-asserted-by":"crossref","first-page":"e978","DOI":"10.1016\/j.ijid.2010.05.018","article-title":"Toxoplasma gondii infection in first-episode and inpatient individuals with schizophrenia","volume":"14","author":"Hamidinejat","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.biopsych.2012.01.003_bib13","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/NMD.0b013e3181c29a23","article-title":"Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders","volume":"197","author":"Arling","year":"2009","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.biopsych.2012.01.003_bib14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1600-0447.2006.00780.x","article-title":"Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia","volume":"114","author":"Wang","year":"2006","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2012.01.003_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.14411\/fp.2010.016","article-title":"The diagnosis of a personality disorder increases the likelihood for seropositivity to Toxoplasma gondii in psychiatric patients","volume":"57","author":"Hinze-Selch","year":"2010","journal-title":"Folia Parasitol (Praha)"},{"key":"10.1016\/j.biopsych.2012.01.003_bib16","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/schbul\/sbm009","article-title":"Early infections of Toxoplasma gondii and the later development of schizophrenia","volume":"33","author":"Mortensen","year":"2007","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2012.01.003_bib17","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.micinf.2009.07.007","article-title":"Serological pattern consistent with infection with type I Toxoplasma gondii in mothers and risk of psychosis among adult offspring","volume":"11","author":"Xiao","year":"2009","journal-title":"Microbes Infect"},{"key":"10.1016\/j.biopsych.2012.01.003_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1176\/appi.ajp.2009.09030361","article-title":"Prenatal infection and schizophrenia: A review of epidemiologic and translational studies","volume":"167","author":"Brown","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.01.003_bib19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.pharmthera.2011.01.014","article-title":"Immune system to brain signaling: Neuropsychopharmacological implications","volume":"130","author":"Capuron","year":"2011","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.biopsych.2012.01.003_bib20","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/archinte.164.9.1010","article-title":"Depression and C-reactive protein in US adults: Data from the Third National Health and Nutrition Examination Survey","volume":"164","author":"Ford","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.biopsych.2012.01.003_bib21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/01.PSY.0000041542.29808.01","article-title":"Association between depression and elevated C-reactive protein","volume":"65","author":"Danner","year":"2003","journal-title":"Psychosom Med"},{"key":"10.1016\/j.biopsych.2012.01.003_bib22","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.pnpbp.2007.02.018","article-title":"Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder","volume":"31","author":"Dickerson","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.01.003_bib23","series-title":"Sample Design: Third National Health and Nutrition Examination Survey, 1988\u20131994","year":"1992"},{"key":"10.1016\/j.biopsych.2012.01.003_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF01788437","article-title":"The diagnostic interview schedule: Its development, evolution, and use","volume":"23","author":"Helzer","year":"1988","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.1016\/j.biopsych.2012.01.003_bib26","series-title":"Laboratory Procedures Used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988\u20131994","author":"Gunter","year":"1996"},{"key":"10.1016\/j.biopsych.2012.01.003_bib27","series-title":"National Health and Nutrition Examination Survey III: Weighting and Estimation Methodology","author":"Mohadjer","year":"1996"},{"key":"10.1016\/j.biopsych.2012.01.003_bib28","series-title":"1992 Proceedings of the Section on Survey Research Methods","first-page":"339","article-title":"Nonresponse adjustment in a national health survey","author":"Ezzati","year":"1993"},{"key":"10.1016\/j.biopsych.2012.01.003_bib29","first-page":"193","article-title":"Confidence intervals for proportions with small expected number of positive counts estimated from survey data","volume":"24","author":"Korn","year":"1998","journal-title":"Surv Methodol"},{"key":"10.1016\/j.biopsych.2012.01.003_bib30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1586\/14737175.8.1.93","article-title":"Neurobiology of bipolar disorder","volume":"8","author":"Newberg","year":"2008","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.biopsych.2012.01.003_bib31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0920-9964(02)00357-2","article-title":"Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii","volume":"62","author":"Jones-Brando","year":"2003","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2012.01.003_bib32","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1098\/rspb.2005.3413","article-title":"Parasites as causative agents of human affective disorders?","volume":"273","author":"Webster","year":"2006","journal-title":"Proc Biol Sci"},{"key":"10.1016\/j.biopsych.2012.01.003_bib33","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/mp.2010.7","article-title":"Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility","volume":"16","author":"O'Dushlaine","year":"2011","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.01.003_bib34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1471-2180-11-110","article-title":"Toxoplasma gondii down modulates cadherin expression in skeletal muscle cells inhibiting myogenesis","volume":"11","author":"Gomes","year":"2011","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.biopsych.2012.01.003_bib35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/hmg\/ddq471","article-title":"Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries","volume":"20","author":"Williams","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biopsych.2012.01.003_bib36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clim.2005.01.003","article-title":"HLA class II involvement in HIV-associated Toxoplasmic encephalitis development","volume":"115","author":"Habegger de Sorrentino","year":"2005","journal-title":"Clin Immunol"},{"issue":"suppl 1","key":"10.1016\/j.biopsych.2012.01.003_bib37","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1086\/337999","article-title":"Host resistance in the brain against Toxoplasma gondii","volume":"185","author":"Suzuki","year":"2002","journal-title":"J Infect Dis"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322312000108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322312000108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T10:21:42Z","timestamp":1543227702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322312000108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0006322312000108"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2012.01.003","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}